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Topography of itch: evidence of distinct coding for
pruriception in the trigeminal nerve
Hjalte H. Andersena, Jesper Elberlingb, Silvia Lo Vecchioa, Lars Arendt-Nielsena*
Introduction: Little is known about the topographical distribution of pruriception (in particular for nonhistaminergic itch), although
conditions with chronic itch frequently occur in distinct anatomic and often bilateral patterns. This study aimed to investigate regional
differences in the sensitivity to itch stimuli by assessing the intensity of itch, pain, and cutaneous neurogenic flare evoked by histamine
and cowhage in different anatomic regions in 20 healthy volunteers.
Methods: Itch was induced by 1% histamine applied with a prick lancet or by insertion of 25± 5 cowhage spicules in 4 regions:
volar/dorsal forearm, lower back, and chin. The duration and intensity of itch and pain following each pruritic stimulus were measured
by a continuous visual analogue scale (VAS0-100). Sensitivity to touch-evoked itch was assessed by von Frey filaments and cutaneous
flare was quantified by full-field laser perfusion imaging.
Results: Peak itch intensity was lower at the chin (19.4 ± 3.6) compared with other areas (mean of 3 locations; 41.3±4.4),
independently of whether histamine or cowhage was applied (P<0.01). Baseline sensitivity to touch-evoked itch was higher on the
chin (P<0.01), but here hyperknesis did not develop in contrast to other areas (P< 0.05). Cutaneous flare was more intense but had
a smaller dispersion at the chin, compared with other areas (P< 0.01).
Discussion: In conclusion, sensitivity to histaminergic and non-histaminergic itch diverges considerably between body regions.
Lower density of pruriceptive CMH and CMI-neurons or distinct neuronal substrates for itch in the mandibular part of the trigeminal
area may explain the observed reduced itch and vasomotor responses.
Keywords: Itch, Histaminergic itch, Human surrogate models of itch, Topography, Pruriception, Cutaneous flare
1.Introduction
Itch is a cardinal symptom for a range of dermatologic conditions,
such as atopic dermatitis (AD), urticaria, psoriasis as well as several
neurological, hematological, and nephrologic conditions[1,2]. To
date, little fundamental evidence exists regarding potential anatomic
differences in sensitivity to, and processing of various itching stimuli.
This is despite the fact that the first assessments of the topographical
distribution and spatial acuity for touch across the body were pub-
lished more than a century ago[3] and that topography and regional
acuity of the nociceptive system have been explored in the recent
decades[4,5]. The interest in the topography of itch sensation was
recently rekindled in a study showing notable differences between
mechanically induced itch for spinal versus trigeminal innervated
areas[6], and is of principal relevance for 3 primary reasons. (1)
Lesions in dermatological itch conditions often occur in distinct
anatomic patterns. Psoriasis lesions are typically bilateral and occur
very rarely in the trigeminal region, as opposed to neuropathic
pruritus conditions[7,8], whereas prurigo nodularis and dermatitis
herpetiformis occur mainly on extensor surfaces of the
extremities[9,10]. AD lesions are overrepresented in the elbow and
knee creases while urticaria manifests frequently on the trunk and
proximal extremities[11]. Such spatial patterns of skin lesions and
associated sensations of itch and pain in various conditions have
typically been attributed to differences in skin biology, and/or pro-
neness to low intensity damage at different body sites as well as
immunologic factors[12–16]. However, potential neuroanatomic dif-
ferences in the receptiveness or coding of itch at different body sites
have only been marginally investigated. (2) Knowledge on the basic
outline of and differences related to the functional and molecular
properties of pruriceptive system across the body is important to
develop and optimize antipruritic treatment[17,18]. (3) The majority
of human experimental studies applying itch provocations in healthy
volunteers or patients with itch have done so only on the forearms[17]
(contrasting rodent studies on itch, where pruritogens are frequently
applied to the back or to the cheek in order to achieve distinct
behavioral responses[19]).
Itch is transmitted by 2 distinct pathways; a subset of noci-
ceptive mechano-insensitive C-fibers (CMI) convey histaminer-
gic itch and a subset of nociceptive C-mechano-heat C-fibers
(CMH) transmit nonhistaminergic itch[20,21]. Compelling evi-
dence suggests that chronic itch conditions may rely pre-
ferentially on activity in one of these pathways; for example, the
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histaminergic pathway seems to play a major role in chronic
urticaria, whereas the nonhistaminergic pathway has been
suggested to be implicated in AD, thus also explaining why these
conditions are often responsive and intractable to antihistamines,
respectively[18,22,23].
The aim of this study was to investigate the topographical
distribution of itch and nociceptive sensations induced by hista-
minergic and nonhistaminergic itch provocations at 4 different
spinal and trigeminal anatomic regions. In addition, cutaneous
flare responses, wheal reactions, and sensitivity to touch-evoked
itch (STI) at baseline and after each itch provocations were
assessed.
2. Methods
2.1. Study design and subjects
A total of 20 healthy volunteers (10 females, 25.5 ± 0.9 y) were
included in the study. Exclusion criteria were any previous or
current musculoskeletal, neurological, dermatologic, allergic,
and addictive disorders in addition to any ongoing itch, pain, or
discomfort at the day of the experiment. All subjects signed the
informed consent before the experimental procedures. Of the 10
young male subjects participating in the study, 5 had no dis-
cernible beard growth in the assessed facial area, the remaining 5
subjects were instructed to shave the areas approximately 24
hours before the experimental session. The study protocol was
approved by the regional Ethics Committee under the jurisdiction
of the Danish Medicines Agency (approval no.: N-20150058)
and was carried out with a balanced randomization of both the
order of application of histamine versus cowhage, anatomic
location, and dominant versus nondominant side. The following
4 locations were chosen (Figs. 1A–D) for itch provocations: (1)
the middle of dorsal forearm (≈C7), (2) the chin, that is, the lower
half of the territory of the mandibular branch of the trigeminal
nerve (TN), (3) the middle of back (≈T12–L2), and (4) the middle
of the volar forearm (C5–T1). These locations were based on
prior publications[6,24] and to achieve comparability between
extensor and flexor-surface processing. All experimental proce-
dures of the main study were conducted in one 3-hour session.
2.2. Intraepidermal administration of histamine and cowhage
spicules
A total of 8 areas (4 on each side of the body) were predefined and
marked for subsequent study in accordance with Figures 1A–D.
Itch provocations were conducted in 2 different ways: (1) hista-
minergic itch was evoked using intraepidermal punctures of 1%
histamine with a standard 1mm skin prick test (SPT) lancets
(Allergopharma, Hamburg, Germany). A drop of histamine solu-
tion was placed on the predetermined area and an SPT lancet was
pricked through the histamine using 120 g of weight for 1–2 sec-
onds creating an epidermal puncture. (2) Nonhistaminergic itch
was induced using cowhage spicules, which were prepared imme-
diately before application under a stereomicroscope (Seben incog-
nita microscope, Seben GmbH, Berlin, Germany) using a negative
grip tweezer (Electron Microscopy Science, Dumont, Switzerland).
Approximately 25 spicules were inserted into the center (∅0.5 cm)
of the predefined skin area (∅2.5 cm) within a 15-second interval
using light pressure as previously described[25]. The spicules were
gently removed with tape after all assessments. Both of these itch
provocation methods has previously been found to be reliable[26].
2.3. Assessment of itch and pain
The duration and intensity of itch and pain (“pricking/stinging”
or “warm/burning”) were assessed by a modified visual analogue
scale (VAS) with 3 bars (1 for each sensory quality), following
each itch provocation. A computerized 100-mm VAS ranging
from 0 to 100 (eVAS Software, Aalborg University) installed on a
Samsung Note 10.1 Tablet (Samsung, Seoul, South Korea) was
used. The subjects were instructed to report the occurrence and
intensity of the aforementioned sensations continuously
throughout the 9-minute sampling, which were conducted at 0.2
Hz. On the VAS, 0 indicated “no itch” or “no pain” and 100
indicated “worst imaginable itch” or “worst imaginable pain.”
The subjects were briefly provided with instructions on somato-
sensory rating. “Pricking” was introduced as the sensation
induced from a needle/SPT lancet while “stinging”was described
as, for example, being stung or bitten by an insect. “Warm/
burning” was described the sensation associated with burns or
exposure to chemical irritants. Itch was introduced as a sensation
evoking a desire to scratch, for example, associated with a mos-
quito bite. The subjects were instructed that these sensations
might or might not occur following any of the administered
provocations and instructed only to rate itching/painful sensa-
tions, that is, not detection of innocuous associated sensations
such as tingling. They were also instructed to disregard the mild
initial pricking pain associated with insertion of spicules and the
SPT puncture. From the VAS/time data temporal itch and pain
intensity profiles were generated and area-under-the-curve
(AUC), peak itch/pain intensity, and latency were calculated.
AUC was calculated using the trapezoidal method.
2.4. Touch-evoked itch assessment
STI was probed in the 8 predetermined areas at baseline and
approximately 15 minutes after itch provocations with 3 von
Frey filaments; 9.8, 13.7, and 19.6 mN (North Coast Medical,
Gilroy, CA) by stimulating with each filament 3× 3 times, each
time instructing the subject to report how much itch the stimu-
lation elicited on a numerical rating scale (NRS) from 0 to 10
(with the same outer labels as the previously described VAS).
Subjects were briefly instructed in reporting sensory qualities and
informed before the onset of data collection that itch is defined by
inducing a desire to scratch the area probed with von Frey fila-
ments and hence this should be the hallmark of their rating. The
subjects were also instructed that itch could occur during the von
Frey stimulus itself or immediately after. All mechanical stimuli
were delivered immediately next to the sites of itch provocations
(0.5 to 2 cm distance) within the predefined ∅2.5 cm areas, but
never directly within wheal reactions or the area of spiculae
insertion. A pilot study was conducted with the entire set of 20
calibrated von Frey filaments in a subgroup of 11 subjects to
select the 3 utilized von Frey filaments (see Supplemental Digital
Content 1, http://links.lww.com/ITX/A0 for the applied defini-
tions, methodology, and results). From the reported NRS-values
the total mean was calculated. The applied mechanically induced
itch assessment method did not allow accurate separation of
alloknesis and hyperknesis (because of differences in individual
baseline scores), but instead acted as a composite measure hereof.
Hence, for baseline values the measure is referred to as STI,
Andersen et al. Itch (2017) 2:e02 Itch
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whereas the observed increases in the susceptibility to touch-
evoked itch following itch provocations with histamine and
cowhage are referred to as hyperknesis, as this was prevailing in
the majority of subjects, that is, the incidence of reporting itch in
response to the von Frey triplicate stimuli conducted at baseline
with a NRS cutoff of > 0.5 was: 487/720 or 66.9%.
2.5. Microvascular reactivity to histamine and cowhage
The longest wheal diameter was assessed 9.5 minutes after each
itch provocation in millimeter using a ruler. Cutaneous neuro-
genic flare (assessed by superficial blood perfusion) wasmonitored
in terms of dispersion and flux intensity by the use of full-field laser
perfusion imaging (FLPI). For this purpose a MoorFLPI-1 (Moor
Instruments, Axminster, Devon, UK) was used with a 40 cm dis-
tance between the area and the lens, a 5Hz display rate, a 8.3 ms
exposure time, and 160 units of gain. An image was obtained at
baseline and 10 minutes following each itch provocation and
analyzed using proprietary software (MoorFLPI Review Version
4.0; Moor Instruments). The FLPI data were analyzed by 2
methods: (1) using a region of interest (ROI) approach with a ROI
equivalent to the predefined ∅2.5 cm area giving rise to an
arithmetic mean and a peak perfusion within this area (referred to
as “cutaneous flare”) and (2) a flare size approach wherein the
area associated with the itch provocation and with an ≥50%
increase compared with the surrounding background perfusion
was quantified in cm2 using the ∅2.5 cm area as a reference
(referred to as flare area). These quantification methods are pre-
viously described in detail in Olsen et al[27].
2.6. Control experiment to adjust for baseline superficial
blood perfusion
As superficial skin perfusion rates varies between body regions a
control experiment was conducted to rule out the possibility that
higher local clearance of histamine and mucunain (the active
pruritogen in cowhage) were causing differences in perceived itch
intensity; that is, higher blood perfusion levels in the facial region
could cause a rapid elimination of the used pruritogens. This
subexperiment was conducted separately from the main experi-
ment in 10 random subjects from the main study cohort and
provocations were performed in 4 areas; on each volar forearm
(being the most commonly investigated site) and on each chin
(being the site with the highest baseline perfusion levels).
Histamine application, VAS recording, and assessment of
superficial blood perfusion were conducted as previously descri-
bed with the exception that the VAS recording was extended to
20 minutes (due to the possibility that itch and pain sensations
would last longer). To decrease superficial blood perfusion a
topical α2-adrenergic-agonist brimonidine (0.33% gel; Mirvaso,
La Défense, France) or vehicle (inert gel) was applied 20 to
30 minutes before each itch provocation.
2.7. Statistical analysis
Statistical analyses were performed using SPSS (version 23, IBM
Corporation, Armonk, NY). Sample size calculations were con-
ducted based on previously obtained data applying similar itch
induction models in a test-retest study[26] and using the approach
outlined in Mørch et al[28] for crossover designs. The obtained
data are presented as arithmetic means ± SE of the mean (SEM).
Figure 1. Applied body regions (A–D) andmethodology (E and F). Approximate location of provocations with histamine and cowhage on the dorsal forearm (A), chin
(B), back (C), and volar forearm (D). Typical cutaneous flare responses (F) measured by full-field laser imaging perfusion (FLPI) at baseline and in response to
cowhage and histamine (subject no. 10). Using von Frey filaments in a specific force range (F) assessment of mechanically evoked itch sensitivity was conducted.
Anatomic illustrations were modified from Navigate Pain© with permission by Aglance Solutions ApS (#NP02002).
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Data from all assessments were tested for normality using visual
inspection and if unclear, the Shapiro-Wilk normality test with
and without log-transformation. Peak (primary outcome), and
AUC of itch/pain profiles were calculated and compared from
VAS recordings. The primary statistical analyses for all outcome
measures of the primary experiment were performed with repe-
ated measures analysis of variance using Sidak post hoc tests. For
itch and pain outcomes the test was constructed with exposure (2
levels) and location (4 levels), whereas for STI and FLPI data an
additional baseline level was added to the exposure factor.
Mauchly’s test of sphericity was utilized and in cases where
sphericity was violated the Greenhouse-Geisser correction was
applied. For the control experiment the Student t test was used to
compare VAS and FLPI data. For an overview of the differences
characterizing STI across the 4 sitesZ-score transformations were
made. For STI the relative increases after histamine and cowhage
provocations were analyzed. The Pearson correlation analyses
were conducted between parameters of particular interest, that is,
peak itch intensities for histamine and cowhage at various loca-
tions and between peak itch intensities for histamine versus
cutaneous flare areas in line with previously suggested
associations[29]. A P-value of ≤ 0.05 was considered significant
for all analyses.
3. Results
All subjects recruited for the experiment completed the study
without experiencing any adverse reactions during or after the
completion of the study. Refer to supplementary material 1 (Fig.
S1, Supplemental Digital Content 1, http://links.lww.com/ITX/
A0) for results of the initial study performed to optimize von Frey
force range used to assess STI.
3.1. Itch sensations evoked by histamine and cowhage
Temporal profiles of itch and pain sensations following provo-
cations with histamine and cowhage are depicted in Figures 2A–
D. An effect of location was observed for both itch peak intensity
(F3,57=20.5, P<0.001) and itch AUC, and post hoc compar-
isons showed that the itch peak intensity in the chin was highly
reduced compared with all other areas (P<0.001). The lowest
effect size was found between the peak itch intensity of the dorsal
forearm (VAS= 39.9 ± 4.7) and the chin (VAS= 19.34 ± 2.6),
P< 0.001 (Fig. 2E) and the lowest effect size for AUC was found
between the itch AUC of the lower back (VAS×min= 20.2 ± 2.6)
and the chin (VAS× time=8.1 ± 1.3) (P< 0.001; Fig. 1F). No
differences were observed between the remaining 3 areas
(P< 0.97) for peak itch intensity. There was a nonsignificant
main effect trend for exposure (F1,19=4.024, P=0.059), sig-
nifying that cowhage produced insignificantly higher itch peak
intensity scores than histamine. As for peak itch intensity, itch
AUC was dependent on location (F3,57= 20.5, P< 0.001), and
post hoc comparisons showed that the itch AUC in the chin was
highly reduced compared with all other areas (P< 0.05). There
was no main effect of exposure for itch AUC (F1, 19=0.3,
P= 0.571) and the exposure× location interaction was non-
significant (F3,57=2.47, P= 0.071), indicating that the observed
differences for locationwere independent of whether histamine or
cowhage were applied (although a trend was evident).
3.2. Pain sensations evoked by histamine and cowhage
Both histamine and cowhage gave rise to mild nociceptive sen-
sations occurring alongside the itch (Figs. 2G, H). However,
sensations rated as “warm/burning” pain never reached an
average peak VAS above >5, and this outcome parameter was
not subjected to further analysis. For “pricking/stinging” pain,
peak intensities was found to be significantly higher for cowhage
(VAS=21.1) than for histamine (VAS=11.8) across locations
shown by a main effect for exposure (F1,19= 14.01, P<0.001).
No overall difference was found for location (F3,57= 0.49,
P= 0.69); however, a significant interaction was found for loca-
tion× exposure (F3,57=3.47, P=0.022; Fig. 2G). Cowhage
induced higher peak pain levels than histamine specifically on the
dorsal forearm (P<0.01) and on the lower back (P<0.01) and
similar results were found for pain assessed by AUC. Cowhage
induced higher pain AUC scores than histamine on the dorsal
forearm (P< 0.05) and on the lower back (P< 0.05), and in the
histamine condition higher pain AUC scores was found for volar
forearm versus dorsal forearm and for the volar forearm versus
the lower back (P<0.05).
3.3. Touch-evoked itch sensitivity
STI was quantified at baseline and after each itch provocation
(Supplementary material 1, Supplemental Digital Content 1,
http://links.lww.com/ITX/A0). At baseline a majority of stimulus
triplicates were reported as itch evoking, that is, incidences were
66.1% for the dorsal forearm, 77.7% for the chin, 50.5% for the
lower back, and 73.3% for the volar forearm (NRS cutoff of>
0.5). An isolated analysis of the baseline data (Fig. 3A) showed
significant differences in STI depending on location (F3,57= 13.9,
P< 0.001). Specifically, STI was higher in the chin comparedwith
the dorsal forearm and the lower back (P< 0.01) and was
reduced at the lower back compared with the volar forearm
(P< 0.01). Analysis of hyperknesis after itch provocations
showed main effects of exposure (F2,38= 21.7 P< 0.001) and
location (F3,57=3.03 P< 0.037). An interaction was present
between location and exposure (F6,114= 2.922 P=0.044) and
post hoc tests showed hyperknesis after itch provocations with
both histamine and cowhage, for all areas except the chin
(P< 0.05); that is, cowhage and histamine conditions were
associated with overall higher STI than baseline measurements
(P< 0.01) and before itch provocation the lower back was gen-
erally less sensitive than the chin and the volar forearm (P<0.05)
(Figs. 3B, C).
3.4. Cutaneous flare and wheal reactions
Histamine, but not cowhage, consistently produced wheal reac-
tions with an average of the longest diameter being 4.8 ± 0.3 mm.
The repeated measures analysis of variance showed no effect of
location (F1.9,33.5=2.59 P=0.091) signifying that wheal reac-
tions did not differ between locations. Cutaneous flare was con-
sistently induced by histamine while cowhage only occasionally
gave rise to minor responses (Fig. 1E). Superficial blood perfusion
measurements were shown to be dependent on the location
(P< 0.001), that is, higher levels of baseline perfusion measured
by ROI mean and ROI peak were present in the chin compared
with all other locations (Fig. 4A). Histamine (average,
7.24 ± 0.71 cm2) produced more consistent and larger flare areas
than cowhage (average, 0.85 ± 0.36 cm2) (F1,19=131.9,
Andersen et al. Itch (2017) 2:e02 Itch
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P< 0.001). In total, only 24 of 80 cowhage provocations resulted
in discernable but small flare areas (Fig. 4D). The size of flare
areas in response to histamine were significantly diminished at the
chin (3.51 ± 0.49 cm2) compared with all other areas (average,
8.50 ± 0.73 cm2; P<0.01) and flare areas in response to
histamine were larger on the volar arm (9.59 ± 0.67 cm2) than on
the lower back (7.10 ± 0.81 cm2, P<0.05; Fig. 4D). A significant
correlation between the area of cutaneous flare and the peak itch
intensity across all areas was found (r2=0.43, 95% confidence
interval, 0.23-0.64; P<0.001; n= 80).
Figure 2. Temporal profiles of itch (A and B) and pain (C and D) across the 4 sites. Peak and AUC of evoked itch (E and F) and pain (G and H). */#P≤0.05,
**/##P≤0.01. #Significance in comparison with all other conditions of the parameter. AUC indicates area-under-the-curve; VAS, visual analogue scale.
Andersen et al. Itch (2017) 2:e02 www.itchjournal.com
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3.5. Control experiment to adjust for baseline superficial
blood perfusion
Brimonindine reduced baseline superficial perfusion (Fig. 5D)
particularly at the chin (P< 0.01) where perfusion rates were
reduced to levels equal to those of the volar forearm without
brimonidine treatment (P>0.8). Peak itch intensity and peak
latency were unchanged by the pretreatment of brimonidine
versus vehicle (Figs. 5A–C). A larger AUC was observed for
Figure 3. Differences between susceptibility to mechanical itch stimuli at baseline (A), degree of hyperknesis developed after each itch provocation (B), and
Z-transformed results (C) at baseline (yellow) and increases signifying relative hyperknesis after itch provocations. For histamine (red) and cowhage (green) results in
(C), relative increases in mechanically evoked itch sensitivity are compared with the dataset mean. *P≤ 0.05, **P≤0.01. Z-transformation of baseline STI scores
and relative increases prompted by histamine and cowhage show the chin being more sensitive at baseline while the lower back is less sensitive and how
hyperknesis did not occur at the chin after either histamine or cowhage provocations (C). NRS indicates numerical rating scale; STI, sensitivity to touch-evoked itch.
Figure 4. Baseline differences in perfusion (A), relative increases in mean perfusion across different sites (B), relative increases in peak perfusion across different
sites (C), and the flare area (D). */#P≤0.05, **/##P≤ 0.01. #Significance in comparison with all other conditions of the parameter.
Andersen et al. Itch (2017) 2:e02 Itch
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histamine on the volar forearm as a consequence of a slowed
decline of itch (P<0.05).
4. Discussion
The intensity of histaminergic and nonhistaminergic itch and
vascular responses evoked by itch provocation models differs
greatly between different anatomic areas. Most notably, itch
sensitivity to both histaminergic and nonhistaminergic stimuli
was highly reduced at the TN-innervated area. Here, both itch
provocations resulted in lower peak and AUC itch scores com-
pared with all other areas investigated and on average the
reduction amounted to ≈55%. Itch-associated nociceptive sen-
sations, that is, “pricking/stinging” were found not to depend on
location for either histamine or cowhage, indicating that the
observed topographical differences are specific to itch.
Conversely, STI was increased at the chin, but hyperknesis after
itch provocations did not develop despite the fact that ≈2-fold
sensitivity increases were found for all other tested locations.
Lastly, distinct patterns were observed for the cutaneous flare
response; at the chin, reactions in response to histamine were
more intense but highly localized, whereas in the other regions
more widespread and less intensive inflammatory responses were
observed.
4.1. Itch and pain induction by histamine and cowhage
The temporal itch intensity profiles (Figs. 2A–D), evoked in
response to histamine and cowhage on all locations apart from
the chin, are well aligned with previous research applying these
human surrogate models of itch[25,29–31]. Earlier studies on
cowhage and histamine-induced itch have reported that the sen-
sation of itch frequently occurs together with pricking/stinging
and warm/burning sensations[30,31]. The present study also
showed pricking/stinging pain after both cowhage and histamine
application, although not to the same extent as some previous
publications[25,30]. In addition, very low levels of burning pain
were observed and generally reported to be slightly lower than in
previous studies[30,31]. These discrepancies may be caused by
methodological differences regarding definitions of labels, deliv-
ery method of histamine and cowhage, sampling frequency, dif-
ferent VAS’, and the multiplicity of repeated provocations
applied in the present study. Surprisingly, itch evoked by both
histamine and cowhage was significantly decreased at the chin,
whereas nociceptive sensations did not show a similar anatomic
distribution. A lack of notable and consistent differences between
extensor and flexor surfaces was observed for both cowhage and
histamine provocations. Thus it is unlikely that itch fiber topo-
graphy of histaminergic and mucunain-responsive fibers is etio-
logically involved in itch conditions characterized by manifesting
preferentially on flexor or extensor surface skin.
Figure 5. Itch intensity profiles and superficial blood perfusion induced by histamine before and after brimonidine treatment at the chin and volar forearm (n=10).
Temporal itch profiles (A), peak itch intensity (B), peak itch latency (C), and superficial blood perfusion measured as mean and peak intensity (D). #P≤0.05,
##P≤ 0.01. #Significance in comparison with all other conditions of the parameter. Notice that no significant (NS, highlighted) difference is present for superficial
perfusion between the chin after brimonidine pretreatment versus the volar forearm at baseline. Superficial blood perfusion at baseline did not affect the peak itch
intensity scores obtained (P>0.8). VAS indicates visual analogue scale.
Andersen et al. Itch (2017) 2:e02 www.itchjournal.com
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4.2. Topography of itch induced by histamine, cowhage, or
von Frey stimulation
Topographical sensitivity to itch stimuli is a sparsely investigated
topic. To our knowledge only 4 previous studies have explored
itch sensitivity in a territory innervated by the TN[6,24,32,33].
These studies generally find decreased itch scores in various TN-
innervated areas in response to histamine most commonly
applied by iontophoresis (a method more prone to differences in
barrier integrity than SPT) compared with the volar forearm, in
line with this study. Fukuoka and colleagues, notably reported
that while itch scores in response to histamine iontophoresis were
generally decreased by approximately 50% at the chin versus the
forearm, touch-evoked itch as well as tickle scores were much
more vigorous in face than on the volar forearm where almost no
itch was elicited. The devised mechanical stimulation technique
relied on vellus-hair vibration and is hence influenced by their
regional distribution but nonetheless the observation supports
the current findings of increased STI in the face which also aligns
with the classical functional distribution of mechano-receptive
fibers; face> arm> thorax[3,4]. It should be noted that sensations
such as “tingling” or “crawling” in response to von Frey stimuli
were not quantified in this study, but that these are likely much
more readily evoked in the facial region[6]. The presented data on
histaminergic itch sensitivity are aligned with a previous psy-
chophysical study in which a dose-response design (intradermal
histamine) was applied in various spinally innervated
locations[34] and a previous study showing decreased histami-
nergic responsiveness in skin of the scalp[35]. Lastly, the present
data are also in agreement with a preclinical study in which
intradermal injection of serotonin (5-HT) elicited significantly
more hindlimb scratch bouts, and more prolonged scratching, in
a spinal versus trigeminal area[36] (although such behavioral data
should be interpreted with caution).
In the present study we used von Frey filaments in a pre-
optimized force range to probe itch sensitivity at baseline and
after each provocation. Using von Frey filaments to probe itch
and pain sensitivity has been described earlier, for example, to
document increased sensitivity to mechanically evoked itch and
pain in patients with AD[37–39], but it has not been studied sys-
tematically for different forces nor across different body regions
before and after itch provocations. As the test-retest reliability of
probing mechanical pain sensitivity with von Frey filaments is
relatively poor, pain in response to the von Frey set of 20 fila-
ments was only quantified in the pilot study (supplementary
material 1, Supplemental Digital Content 1, http://links.lww.
com/ITX/A0). In this context it should be noted that one previous
study did not detect pain in normal skin to any of the 20
filaments[40], contradicting the current and several previous
studies[37–39,41].
Hyperknesis developed in response to both cowhage and his-
tamine in all areas apart from the chin (as previously shown on
the volar forearm[42]). The lack of significant hyperknesis after
itch provocations on the chin is likely a consequence of the limited
pruriceptive drive or simply that this location is much more
sensitive to touch-evoked itch at baseline causing a ceiling
effect[43]. It remains unclear which neuronal structures that
convey touch-evoked itch. Aδ-nociceptors are probable sub-
strates given their involvement in pinprick hyperalgesia[44], but
tactile C-fibers have also been proposed[6] and a very recent study
broadly suggested low threshold mechano-receptors as a primary
afferent candidate for mechanically evoked itch transduction in
hairy skin and revealed that a dedicated spinal cord inhibitory
pathway characterized by the expression of neuropeptide Y that
gates the transmission of touch-evoked itch under normal con-
ditions[45,46]. Although speculative, the fact that touch-evoked
itch is more readily elicited in the face while chemically induced
histaminergic or nonhistaminergic itch (as presently shown) is
more readily induced on, for example, extremities could be evo-
lutionarily driven[6]. While, skin contact with irritant or aller-
genic plants is likely to occur for extremities it is less likely to
occur in the face. Conversely, poisonous insects (the detection of
which requires sensitive processing of tactile stimuli) are poten-
tially more damaging to structures in the facial region than on the
extremities.
4.3. Cutaneous flare responses to histaminergic itch
The finding that the extent of the cutaneous flare in response to
histamine is smaller, but of higher magnitude in a trigeminal area
versus, for example, on the volar forearm has previously been
observed for intradermal capsaicin injections and is thought to
reflect the innervation density, receptive field sizes, and micro-
vascular reactivity[47,48]. The cutaneous flare responses observed
in response to histamine in the present study occur when pepti-
dergic nerve fibers, upon activation and antidromic signaling,
release vasoactive substances, most prominently calcitonin gene–
related peptide, causing microvasculature dilation. Although
both CMH and CMI fibers are capable of producing calcitonin
gene–related peptide, the larger receptive field of CMI fibers
causes much more pronounced responses particularly beyond the
injections site[49]. As such our findings support the notion of
increased density of peptidergic fibers, including Aδ fibers,
characterized by significantly smaller receptive fields in the facial
region compared with the forearms or thorax[50,51] and indicate
that the innervation density and territories of pruriceptive hista-
minergic fibers specifically are smaller at the chin. A significant
positive correlation was observed between the size of the flare
area and the peak itch intensity, conceivably because a subset of
CMI-fibers mediates both histamine-induced itch and the extent
of the flare reaction.
4.4. Limitations
Limitations concerning interpretation of the present results are
foremost related to potential indirect non-neuronal involvement
from factors such as baseline skin perfusion, epidermal thickness,
and temperature all characterized by regional differences[24,52,53].
However, several observations indicate that these factors are not
biasing the present results; for example, epidermal thickness is
relatively uniform across the sites tested[52,54], SPT in any of the
sites rarely resulted in bleedings and wheal reactivity did not
differ significantly (indicating that similar volumes of histamine
were introduced at similar depths). Although increase in skin
temperature is known to aggravate itch and is different between
body regions[53,55], this should, if anything, have increased itch
responses at the chin and superficial skin perfusion is unlikely to
be a major factor as brimonidine pretreatment significantly
reduced perfusion at the chin without changing the itch or pain
peak intensity to histamine application. With the proxy-based
nature of the study in mind we provide compelling
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psychophysical and vasomotor evidence of altered pruriceptive
innervation of the chin, but studies confirming this on amolecular
level are needed. This study shows that elicitation of even mod-
erate chemically induced itch, using the 2 most common human
models of itch, is difficult to achieve in a TN-innervated area in
humans. In this regard it should be noted that certain chronic itch
patient populations, particularly those with neuropathic origins,
frequently experience highly bothersome and treatment refrac-
tory itch in the facial region[7] of which the pathophysiology
remain poorly understood[56] Lastly, it should be mentioned that
the chin, innervated by the mandibular branch of the TN, might
not be representative for itch sensitivity in the entire TN, although
several previous studies also point toward reduced responses to
histamine for both the scalp and forehead[32,35].
In conclusion, itch sensitivity and vascular reactivity to hista-
mine and cowhage provocations differ between body regions and
particularly itch severity in response to both histamine and
cowhage is greatly diminished at the chin while sensitivity to von
Frey filament-induced, touch-evoked itch is increased. It is
hypothesized that the observed differences are caused by lower
density of pruriceptive CMH and CMI-neurons (peripheral) or
by altered neuronal coding (central) of itch in the trigeminal
region, for example, more reliant on mechano-receptive input.
Our study suggests that itch in different anatomic regions have
different neuronal substrates and could hence respond differently
to various therapeutic interventions. Comparative analysis of itch
processing and pruriceptive receptor expression in the dorsal root
ganglion versus trigeminal neurons might yield targets for future
antipruritic therapy.
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